Category: 4. Health

  • Daylight Saving Time May Increase Strokes and Obesity

    Daylight Saving Time May Increase Strokes and Obesity

    A new study published in the Proceedings of the National Academy of Sciences has shown that switching to permanent standard time could save millions of Americans from serious health risks such as strokes and obesity. Switching clocks twice a year disrupts circadian rhythms and may have serious health consequences for Americans.

    The study modelled the health impact of three different potential time policies on Americans: permanent standard time,…

    Continue Reading


    News Source: www.labroots.com

  • Novel Biomarkers Revealed in Pediatric Germ Tumors

    Novel Biomarkers Revealed in Pediatric Germ Tumors

    Although pediatric cancer is rare, it is the leading cause of death by disease in children, according to the National Institutes of Health (NIH). Over 16,000 children in the United States are currently diagnosed with cancer. Among the types of cancers diagnosed, most are leukemias, brain tumors, lymphomas, and central nervous system (CNS) tumors. However, 3% of all childhood cancers under 15 years old include pediatric germ cell tumors (GCTs). Adolescents…

    Continue Reading


    News Source: www.labroots.com

  • Combination Therapy Overcomes Glioblastoma Resistance

    Combination Therapy Overcomes Glioblastoma Resistance

    Glioblastoma is the most common and aggressive form of brain cancer in adults. There are about 12,000 new cases diagnosed each year in the United States. There are many different risk factors that could lead to glioblastoma. Age is a large risk factor as well as family history and environmental exposure. Symptoms include headaches, seizures, confusion/memory loss, difficulty speaking or understanding speech, vision problems, nausea, vomiting, and…

    Continue Reading


    News Source: www.labroots.com

  • Trump’s $100,000 H-1B Visa Fee Could Deepen America’s Doctor Shortage

    Trump’s $100,000 H-1B Visa Fee Could Deepen America’s Doctor Shortage

    When the White House announced that all new H-1B visa petitions would now carry a $100,000 supplemental fee, headlines quickly focused on tech. Silicon Valley has long relied on H-1B visas to recruit engineers from abroad. Yet the bigger impact may not fall on code-writers in California, but on deepening the doctor shortage in communities already struggling.

    With hospitals struggling to find enough staff, this…

    Continue Reading


    News Source: www.forbes.com

  • Gene Therapy Could End Lifelong Transfusions For Rare Blood Disorder

    Gene Therapy Could End Lifelong Transfusions For Rare Blood Disorder

    A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the burden of lifelong transfusions. For patients, this would mean liberation from weekly or monthly hospital visits, reduced risk of organ damage caused by iron overload, and a vastly improved…

    Continue Reading


    News Source: www.forbes.com

  • This high-sugar fruit may actually lower diabetes risk

    This high-sugar fruit may actually lower diabetes risk

    If presented with two snacks, one containing seven grams of sugar and another with over 30 grams of sugar, choosing the healthier option should be a no-brainer, correct? Well, maybe not. Less sugar is not automatically healthier.

    For the nearly 100 million adults in the United States who are currently living with prediabetes, a tropical fruit that can reduce the risk of diabetes sounds too good to be true. Tropical fruits contain anywhere between ten to 50 grams of sugar, with mangos on the…

    Continue Reading


    News Source: www.sciencedaily.com

  • Smart Scales Are Dumb. ShapeScale Redefines Longevity In The GLP-1 Era

    Smart Scales Are Dumb. ShapeScale Redefines Longevity In The GLP-1 Era

    As GLP-1 drugs like Ozempic boom, ShapeScale’s 3D body scanner claims DXA-level accuracy—revealing whether patients are truly losing fat or critical muscle.

    Losing weight isn’t the problem. Losing muscle is. That’s the blind spot ShapeScale is betting on — and why doctors now call muscle the body’s most important organ of longevity.

    Smart scales are everywhere — brands like Withings, Renpho, Fitbit, and Eufy promise a window into your…

    Continue Reading


    News Source: www.forbes.com

  • Hidden bacterial molecules in the brain reveal new secrets of sleep

    Hidden bacterial molecules in the brain reveal new secrets of sleep

    What causes us to sleep? The answer may lie not only in our brains, but in their complex interplay with the micro-organisms spawned in our intestines.

    New research from Washington State University suggests a new paradigm in understanding sleep, demonstrating that a substance in the mesh-like walls of bacteria, known as peptidoglycan, is naturally present in the brains of mice and closely aligned with the sleep cycle.

    Those findings serve to update a broader hypothesis that has been in…

    Continue Reading


    News Source: www.sciencedaily.com

  • Brain fat, not just plaques, may be the hidden driver of Alzheimer’s

    Brain fat, not just plaques, may be the hidden driver of Alzheimer’s

    It was long thought that fat in the brain played no role in neurodegenerative diseases, but Purdue University researchers are challenging that assumption.

    The research findings, published in Immunity, show that excess fat in the brain’s resident immune cells, called microglia, impairs their ability to combat disease. This insight opens a path to lipid biology-based neuroimmune therapies that could treat diseases like Alzheimer’s by enhancing microglial function and neuronal health. This work…

    Continue Reading


    News Source: www.sciencedaily.com

  • Scientists reveal pill that helps shed 20% of body weight

    Scientists reveal pill that helps shed 20% of body weight

    New research presented at the Annual Meeting of the European Association for the Study of Diabetes in Vienna, Austria (Sept 15-19) and simultaneously published in NEJM shows that daily treatment with the new once-daily GLP-1 agonist orforglipron results in substantial weight loss in people living with obesity that do not have type 2 diabetes. The study is by Dr Sean Wharton, McMaster University, Hamilton, ON, Canada and Wharton Weight Management Clinic, Burlington, ON, Canada, and…

    Continue Reading


    News Source: www.sciencedaily.com